| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8241639 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 6 Pages |
Abstract
Conclusions: Both cisplatin and radiation therapy were proven to induce sensorineural hearing loss, in this study with short-term follow-up. Of all patient and treatment variables studied, the patients pretreatment hearing level appeared to be the main predictive factor for hearing capability after high-dose intra-arterial cisplatin chemoradiation.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Charlotte L. M.D., Yvonne J. M.Sc., Pauline E. B.S., Augustinus A. M.Sc., Coen R. M.D., Jan H. M.D., Wouter A. M.Sc., Alfons J. M.D.,